Cargando…

First person – Monika J. Tomecka

First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms (DMM), helping early-career researchers promote themselves alongside their papers. Monika Tomecka is first author on ‘Clinical pathologies of bone fracture modelled in...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Company of Biologists Ltd 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6765197/
http://dx.doi.org/10.1242/dmm.041848
_version_ 1783454519479238656
collection PubMed
description First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms (DMM), helping early-career researchers promote themselves alongside their papers. Monika Tomecka is first author on ‘Clinical pathologies of bone fracture modelled in zebrafish’, published in DMM. Monika conducted the research described in this article while a PhD student in Tom Carney's lab at the Institute of Molecular and Cell Biology (IMCB), A*STAR (Agency for Science, Technology and Research), Singapore and Henry Roehl's lab, Department of Biomedical Science, The University of Sheffield, UK. She is now a CEO at uFraction8, an engineering company that develops biotech instruments for industrial cell culture harvesting.
format Online
Article
Text
id pubmed-6765197
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher The Company of Biologists Ltd
record_format MEDLINE/PubMed
spelling pubmed-67651972019-10-03 First person – Monika J. Tomecka Dis Model Mech First Person First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms (DMM), helping early-career researchers promote themselves alongside their papers. Monika Tomecka is first author on ‘Clinical pathologies of bone fracture modelled in zebrafish’, published in DMM. Monika conducted the research described in this article while a PhD student in Tom Carney's lab at the Institute of Molecular and Cell Biology (IMCB), A*STAR (Agency for Science, Technology and Research), Singapore and Henry Roehl's lab, Department of Biomedical Science, The University of Sheffield, UK. She is now a CEO at uFraction8, an engineering company that develops biotech instruments for industrial cell culture harvesting. The Company of Biologists Ltd 2019-09-01 2019-09-03 /pmc/articles/PMC6765197/ http://dx.doi.org/10.1242/dmm.041848 Text en © 2019. Published by The Company of Biologists Ltd http://creativecommons.org/licenses/by/4.0This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
spellingShingle First Person
First person – Monika J. Tomecka
title First person – Monika J. Tomecka
title_full First person – Monika J. Tomecka
title_fullStr First person – Monika J. Tomecka
title_full_unstemmed First person – Monika J. Tomecka
title_short First person – Monika J. Tomecka
title_sort first person – monika j. tomecka
topic First Person
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6765197/
http://dx.doi.org/10.1242/dmm.041848